In transient Bartter syndrome, dysregulation of NCC is evidenced by its aberrant expression in the fetal kidney in a tBS patient, a finding corroborated in vitro by showing significantly increased NCC cell surface expression upon MAGED2 overexpression [5]. This evidence concerns the gene SLC12A3 and Bartter syndrome.